{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T19:11:56Z","timestamp":1790622716656,"version":"4.1.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1124\/jpet.121.001048","type":"journal-article","created":{"date-parts":[[2022,2,13]],"date-time":"2022-02-13T15:40:14Z","timestamp":1644766814000},"page":"129-136","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Pharmacological Profiling of Antifentanyl Monoclonal Antibodies in Combination with Naloxone in Pre- and Postexposure Models of Fentanyl Toxicity"],"prefix":"10.1016","volume":"381","author":[{"given":"Carly A.","family":"Baehr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariah M.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujata G.","family":"Pandit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"Arias-Umana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"AuCoin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Pravetoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.121.001048_bib1","series-title":"Provisional drug overdose death counts","author":"Ahmad","year":"2021"},{"key":"10.1124\/jpet.121.001048_bib2","series-title":"COVID-19 Impact on US National Overdose Crisis","author":"Alter","year":"2020"},{"key":"10.1124\/jpet.121.001048_bib3","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1124\/jpet.120.000124","article-title":"Monoclonal antibodies counteract opioid-induced behavioral and toxic rffects in mice and rats","volume":"375","author":"Baehr","year":"2020","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.121.001048_bib4","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2021.1991552","article-title":"Novel chimeric monoclonal antibodies that block fentanyl effects and alter fentanyl biodistribution in mice","volume":"13","author":"Ban","year":"2021","journal-title":"MAbs"},{"key":"10.1124\/jpet.121.001048_bib5","series-title":"Opioid Toxicity","author":"Dolinak","year":"2017"},{"key":"10.1124\/jpet.121.001048_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2017.10.020","article-title":"Substance use patterns associated with recent exposure to fentanyl among people who inject drugs in Vancouver, Canada: A cross-sectional urine toxicology screening study","volume":"183","author":"Hayashi","year":"2018","journal-title":"Drug Alcohol Depend"},{"key":"10.1124\/jpet.121.001048_bib7","unstructured":"Hedegaard H, Mini\u00f1o AM, Warner M (2020) Drug Overdose Deaths in the United States, 1999-2018 Key findings Data from the National Vital Statistics System, Mortality."},{"key":"10.1124\/jpet.121.001048_bib8","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/bph.14860","article-title":"Fentanyl depression of respiration: Comparison with heroin and morphine","volume":"177","author":"Hill","year":"2020","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.121.001048_bib9","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1089\/mab.2014.0098","article-title":"Preparation and Characterization of a Monoclonal Antibody Against Morphine","volume":"34","author":"Kashanian","year":"2015","journal-title":"Monoclon Antib Immunodiagn Immunother"},{"key":"10.1124\/jpet.121.001048_bib10","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1124\/dmd.105.004234","article-title":"Monoclonal nicotine-specific antibodies reduce nicotine distribution to brain in rats: dose- and affinity-response relationships","volume":"33","author":"Keyler","year":"2005","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.121.001048_bib11","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1124\/jpet.118.251504","article-title":"A monoclonal antibody against 6-acetylmorphine protects female mice offspring from adverse behavioral effects induced by prenatal heroin exposure","volume":"368","author":"Kvello","year":"2019","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.121.001048_bib13","series-title":"Trends in Substance Use Disorders Among Adults Aged 18 or Older. The CBHSQ Report.","first-page":"2013","author":"Lipari","year":"2017"},{"key":"10.1124\/jpet.121.001048_bib14","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.15585\/mmwr.mm6934a1","article-title":"Nonfatal drug and polydrug overdoses treated in emergency departments - 29 States, 2018\u20132019","volume":"69","author":"Liu","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1124\/jpet.121.001048_bib15","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1124\/dmd.118.083857","article-title":"A recombinant humanized anticocaine monoclonal antibody alters the urinary clearance of cocaine and its metabolites in rats","volume":"47","author":"Marckel","year":"2019","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.121.001048_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.108974","article-title":"Fentanyl causes naloxone-resistant vocal cord closure: A platform for testing opioid overdose treatments","volume":"227","author":"Miner","year":"2021","journal-title":"Drug Alcohol Depend"},{"key":"10.1124\/jpet.121.001048_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0234683","article-title":"Higher naloxone dosing in a quantitative systems pharmacology model that predicts naloxone-fentanyl competition at the opioid mu receptor level","volume":"15","author":"Moss","year":"2020","journal-title":"PLoS ONE"},{"key":"10.1124\/jpet.121.001048_bib18","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1111\/jcpt.13462","article-title":"Overdoses due to fentanyl and its analogues (F\/FAs) push naloxone to the limit","volume":"46","author":"Pergolizzi","year":"2021","journal-title":"J Clin Pharm Ther"},{"key":"10.1124\/jpet.121.001048_bib19","doi-asserted-by":"crossref","first-page":"14647","DOI":"10.1021\/acs.jmedchem.0c01042","article-title":"Therapeutic and prophylactic vaccines to counteract fentanyl use disorders and toxicity","volume":"63","author":"Robinson","year":"2020","journal-title":"J Med Chem"},{"key":"10.1124\/jpet.121.001048_bib20","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.pbb.2009.04.011","article-title":"Passive immunization with a nicotine-specific monoclonal antibody decreases brain nicotine levels but does not precipitate withdrawal in nicotine-dependent rats","volume":"93","author":"Roiko","year":"2009","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/jpet.121.001048_bib21","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1177\/2042098617744161","article-title":"Naloxone dosage for opioid reversal: current evidence and clinical implications","volume":"9","author":"Rzasa Lynn","year":"2018","journal-title":"Ther Adv Drug Saf"},{"key":"10.1124\/jpet.121.001048_bib22","doi-asserted-by":"crossref","first-page":"10489","DOI":"10.1021\/jacs.9b04872","article-title":"Monoclonal antibodies for combating synthetic opioid intoxication","volume":"141","author":"Smith","year":"2019","journal-title":"J Am Chem Soc"},{"key":"10.1124\/jpet.121.001048_bib23","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.4161\/19420862.2014.976431","article-title":"First human study of a chimeric anti-methamphetamine monoclonal antibody in healthy volunteers","volume":"6","author":"Stevens","year":"2014","journal-title":"MAbs"},{"key":"10.1124\/jpet.121.001048_bib24","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1124\/jpet.120.265561","article-title":"Fentanyl but not morphine interacts with nonopioid recombinant human neurotransmitter receptors and transporters","volume":"374","author":"Torralva","year":"2020","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.121.001048_bib25","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1124\/jpet.119.258566","article-title":"Noradrenergic mechanisms in fentanyl-mediated rapid death explain failure of naloxone in the opioid crisis","volume":"371","author":"Torralva","year":"2019","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.121.001048_bib26","unstructured":"UNODC (2019) World Drug Report 2019 Methodology Report, UN."},{"key":"10.1124\/jpet.121.001048_bib27","doi-asserted-by":"crossref","first-page":"385","DOI":"10.4155\/fmc.13.215","article-title":"Fentanyl-related compounds and derivatives: current status and future prospects for pharmaceutical applications","volume":"6","author":"Vardanyan","year":"2014","journal-title":"Future Med Chem"},{"key":"10.1124\/jpet.121.001048_bib28","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.drugalcdep.2016.09.024","article-title":"The effects of a repeated dose of a recombinant humanized anti-cocaine monoclonal antibody on cocaine self-administration in rats","volume":"168","author":"Wetzel","year":"2016","journal-title":"Drug Alcohol Depend"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524002672?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524002672?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.121.001048","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T13:18:18Z","timestamp":1739971098000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524002672"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S0022356524002672"],"URL":"https:\/\/doi.org\/10.1124\/jpet.121.001048","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological Profiling of Antifentanyl Monoclonal Antibodies in Combination with Naloxone in Pre- and Postexposure Models of Fentanyl Toxicity","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.121.001048","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}